Global Contract Pharmaceutical Manufacturing Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Contract Pharmaceutical Manufacturing Market
The research report studies the Contract Pharmaceutical Manufacturing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Contract Pharmaceutical Manufacturing market size is projected to reach US$ 123200 million by 2027, from US$ 82480 million in 2020, at a CAGR of 5.9% during 2021-2027.
Global Contract Pharmaceutical Manufacturing Scope and Segment
The global Contract Pharmaceutical Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Contract Pharmaceutical Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Oral
Injectable
API
Other
by Application, this report covers the following segments
Large Enterprise
Small Medium Enterprise
Global Contract Pharmaceutical Manufacturing market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Contract Pharmaceutical Manufacturing key players in this market include:
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica

TABLE OF CONTENT

1 Market Overview of Contract Pharmaceutical Manufacturing
1.1 Contract Pharmaceutical Manufacturing Market Overview
1.1.1 Contract Pharmaceutical Manufacturing Product Scope
1.1.2 Contract Pharmaceutical Manufacturing Market Status and Outlook
1.2 Global Contract Pharmaceutical Manufacturing Market Size Overview by Region 2016 VS 2030VS 2027
1.3 Global Contract Pharmaceutical Manufacturing Market Size by Region (2016-2027)
1.4 Global Contract Pharmaceutical Manufacturing Historic Market Size by Region (2016-2030)
1.5 Global Contract Pharmaceutical Manufacturing Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Contract Pharmaceutical Manufacturing Market Size (2016-2027)
1.6.1 North America Contract Pharmaceutical Manufacturing Market Size (2016-2027)
1.6.2 Europe Contract Pharmaceutical Manufacturing Market Size (2016-2027)
1.6.3 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size (2016-2027)
1.6.4 Latin America Contract Pharmaceutical Manufacturing Market Size (2016-2027)
1.6.5 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size (2016-2027)

2 Contract Pharmaceutical Manufacturing Market Overview by Type
2.1 Global Contract Pharmaceutical Manufacturing Market Size by Type: 2016 VS 2030 VS 2027
2.2 Global Contract Pharmaceutical Manufacturing Historic Market Size by Type (2016-2030)
2.3 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Type (2022-2027)
2.4 Oral
2.5 Injectable
2.6 API
2.7 Other

3 Contract Pharmaceutical Manufacturing Market Overview by Application
3.1 Global Contract Pharmaceutical Manufacturing Market Size by Application: 2016 VS 2030 VS 2027
3.2 Global Contract Pharmaceutical Manufacturing Historic Market Size by Application (2016-2030)
3.3 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (2022-2027)
3.4 Large Enterprise
3.5 Small Medium Enterprise

4 Contract Pharmaceutical Manufacturing Competition Analysis by Players
4.1 Global Contract Pharmaceutical Manufacturing Market Size by Players (2016-2030)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contract Pharmaceutical Manufacturing as of 2020)
4.3 Date of Key Players Enter into Contract Pharmaceutical Manufacturing Market
4.4 Global Top Players Contract Pharmaceutical Manufacturing Headquarters and Area Served
4.5 Key Players Contract Pharmaceutical Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Contract Pharmaceutical Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Catalent
5.1.1 Catalent Profile
5.1.2 Catalent Main Business
5.1.3 Catalent Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.1.4 Catalent Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.1.5 Catalent Recent Developments
5.2 DPx
5.2.1 DPx Profile
5.2.2 DPx Main Business
5.2.3 DPx Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.2.4 DPx Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.2.5 DPx Recent Developments
5.3 Lonza
5.3.1 Lonza Profile
5.3.2 Lonza Main Business
5.3.3 Lonza Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.3.4 Lonza Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.3.5 Piramal Healthcare Recent Developments
5.4 Piramal Healthcare
5.4.1 Piramal Healthcare Profile
5.4.2 Piramal Healthcare Main Business
5.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.4.5 Piramal Healthcare Recent Developments
5.5 Aenova
5.5.1 Aenova Profile
5.5.2 Aenova Main Business
5.5.3 Aenova Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.5.4 Aenova Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.5.5 Aenova Recent Developments
5.6 Jubilant
5.6.1 Jubilant Profile
5.6.2 Jubilant Main Business
5.6.3 Jubilant Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.6.4 Jubilant Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.6.5 Jubilant Recent Developments
5.7 Famar
5.7.1 Famar Profile
5.7.2 Famar Main Business
5.7.3 Famar Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.7.4 Famar Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.7.5 Famar Recent Developments
5.8 Boehringer Ingelheim
5.8.1 Boehringer Ingelheim Profile
5.8.2 Boehringer Ingelheim Main Business
5.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.8.5 Boehringer Ingelheim Recent Developments
5.9 Fareva Holding
5.9.1 Fareva Holding Profile
5.9.2 Fareva Holding Main Business
5.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.9.5 Fareva Holding Recent Developments
5.10 AbbVie
5.10.1 AbbVie Profile
5.10.2 AbbVie Main Business
5.10.3 AbbVie Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.10.4 AbbVie Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.10.5 AbbVie Recent Developments
5.11 Nipro Corp
5.11.1 Nipro Corp Profile
5.11.2 Nipro Corp Main Business
5.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.11.5 Nipro Corp Recent Developments
5.12 Vetter
5.12.1 Vetter Profile
5.12.2 Vetter Main Business
5.12.3 Vetter Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.12.4 Vetter Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.12.5 Vetter Recent Developments
5.13 Sopharma
5.13.1 Sopharma Profile
5.13.2 Sopharma Main Business
5.13.3 Sopharma Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.13.4 Sopharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.13.5 Sopharma Recent Developments
5.14 DPT Laboratories
5.14.1 DPT Laboratories Profile
5.14.2 DPT Laboratories Main Business
5.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.14.5 DPT Laboratories Recent Developments
5.15 Recipharm
5.15.1 Recipharm Profile
5.15.2 Recipharm Main Business
5.15.3 Recipharm Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.15.4 Recipharm Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.15.5 Recipharm Recent Developments
5.16 NextPharma
5.16.1 NextPharma Profile
5.16.2 NextPharma Main Business
5.16.3 NextPharma Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.16.4 NextPharma Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.16.5 NextPharma Recent Developments
5.17 Dishman
5.17.1 Dishman Profile
5.17.2 Dishman Main Business
5.17.3 Dishman Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.17.4 Dishman Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.17.5 Dishman Recent Developments
5.18 Aesica
5.18.1 Aesica Profile
5.18.2 Aesica Main Business
5.18.3 Aesica Contract Pharmaceutical Manufacturing Products, Services and Solutions
5.18.4 Aesica Contract Pharmaceutical Manufacturing Revenue (US$ Million) & (2016-2030)
5.18.5 Aesica Recent Developments

6 North America
6.1 North America Contract Pharmaceutical Manufacturing Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Contract Pharmaceutical Manufacturing Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Contract Pharmaceutical Manufacturing Market Dynamics
11.1 Contract Pharmaceutical Manufacturing Industry Trends
11.2 Contract Pharmaceutical Manufacturing Market Drivers
11.3 Contract Pharmaceutical Manufacturing Market Challenges
11.4 Contract Pharmaceutical Manufacturing Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Choose License Type

Checkout Inquiry Sample